GHSA-78f9-745f-278p · Severity: medium · Ecosystem: maven — Neo4j Graph apoc plugins Partial Path Traversal Vulnerability
Neo4j APOC (Awesome Procedures on Cypher) before 4.3.0.7 and 4.x before 4.4.0.8 allows Directory Traversal to sibling directories via apoc.log.stream.
Conclusion & alert: CVE-2022-37423 is rated High Exploit Risk (61.9/100): CVSS High severity, with low exploitation likelihood (EPSS 0.26%). Core evidence: 1 public exploit reference(s) are indexed (Exploit-DB). Mandatory action: Public exploits are available—assess exposure, apply mitigations, and prioritize patching.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
| EDB-ID | Source | Kind | Published | Link |
|---|---|---|---|---|
| — | nvd_ref | exploit_tag | Exploit-DB ↗ |
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2025-12-30 | 0.46% | 0.26% | -0.21% |
| 2 | 2025-11-21 | 0.59% | 0.46% | -0.12% |
| 3 | 2025-11-18 | — | 0.59% | — |
Full EPSS history (12 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 7.5 | 3.1 | HIGH |
|
3.9 | 3.6 | [email protected] |
GHSA-78f9-745f-278p · Severity: medium · Ecosystem: maven — Neo4j Graph apoc plugins Partial Path Traversal Vulnerability
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| neo4j | awesome_procedures_on_cypher | < 4.3.0.7 | cpe:2.3:a:neo4j:awesome_procedures_on_cypher:*:*:*:*:*:*:*:* |
| neo4j | awesome_procedures_on_cypher | >= 4.4.0.0, < 4.4.0.8 | cpe:2.3:a:neo4j:awesome_procedures_on_cypher:*:*:*:*:*:*:*:* |
| URL | Tags |
|---|---|
| https://github.com/neo4j-contrib/neo4j-apoc-procedures/security/advisories/GHSA-78f9-745f-278p | Exploit Third Party Advisory |
| https://neo4j.com/docs/aura/platform/apoc/ | Product Vendor Advisory |